Quanterix (QTRX) Revenue Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Quanterix | 165.84 Mn | 66.57 Mn | 15.57 Mn | 8.57% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.57% |
| Dec 31, 2025 | 19.31% |
| Sep 30, 2025 | 14.72% |
| Jun 30, 2025 | 1.37% |
| Mar 31, 2025 | 0.87% |
| Dec 31, 2024 | 5.10% |
| Sep 30, 2024 | 8.95% |
| Jun 30, 2024 | 10.66% |
| Mar 31, 2024 | 5.63% |
| Dec 31, 2023 | 6.48% |
| Sep 30, 2023 | 0.18% |
| Jun 30, 2023 | 32.88% |
| Mar 31, 2023 | 21.85% |
| Dec 31, 2022 | 17.50% |
| Sep 30, 2022 | 21.26% |
| Jun 30, 2022 | 20.19% |
| Mar 31, 2022 | 33.80% |
| Dec 31, 2021 | 40.69% |
| Sep 30, 2021 | 37.76% |
| Jun 30, 2021 | 43.18% |
| Mar 31, 2021 | 53.51% |
| Dec 31, 2020 | 58.29% |
| Sep 30, 2020 | 76.24% |
| Jun 30, 2020 | 36.06% |
| Mar 31, 2020 | 43.36% |
| Dec 31, 2019 | 106.79% |